In 2008, 7.6 million cancer deaths occurred worldwide. About 60% of cancer deaths occur in low-income and middle-income countries and this number is likely to increase in the future. It is estimated that cancer kills more than a quarter of a million people each year in the WHO Eastern Mediterranean Region alone.
The largest increase in cancer incidence in the next 15 years is also likely to be in the Eastern Mediterranean Region, taking into account the trends for all related risk factors. The most frequent cancers in the Region are breast cancer in females, and lung and bladder cancers in males.
The projected increase in cancer can be attributed to population ageing, better detection and registration, and most importantly, to increased exposure to risk factors. The most important of these factors is tobacco consumption. Other risk factors include unhealthy diet, physical inactivity, other behavioural and lifestyle changes, pollution and increased exposure to industrial and agricultural carcinogens.
The WHO Regional Office is working closely with Member States to overcome these challenges and achieve the objectives of the regional strategy for cancer prevention and control, including palliative care.
National databases on cancer are either lacking or are not up to date in many countries of the Region. WHO is working with Member States to establish national cancer registries, in collaboration with the International Agency for Research on Cancer (IARC).
Newlystar can supply below oncological and supplementary medicine. The product Irinotecan Hydrochloride injection pass Eu GMP.
Anastrozole Tablets, Asparaginase for Injection, Azathiopurine Tablets, Bicalutamide Tablets, Bleomycin A Hydrochloride For Inj, Busulfan Tablets, Calcium folinate for injection, Calcium Levofolinate for Inlection, Carboplatin for Injection, Cisplatin for Injection, Colchicine Tablets, Cyclophosphamide for Injection, Cyclophosphamide Tablets, Cytarabine Hydrochloride for Injection, Dacarbazine for Injection, Daunorubicin Hydrochloride for Injection, Dexrazoxane for Injection, Docetaxel for Injection, Docetaxel Injection, Doxorubicin Hydrochloride for Injection, Doxorubicin Hydrochloride Liposome Injection, Epirubicin Hydrochloride for Injection, Etoposide Injection, Fludarabine Phosphate for Injection, 5-Fluorouracil for Injection, Fluorouracil tablets, Ftorafur Injection, Ftorafur Tablets, Gemcitabine hydrochloride for injection, Gimeracil and Oteracil Porassium Capsules, Gimeracil and Oteracil Porassium Capsules, Granisetron Hydrochloride and Glucose Injection, Granisetron Hydrochloride Injection, Granisetron Hydrochloride Tablets, Hydroxycarbamide Tablets, Idarubicin Hydrochloride for Injection, Ifosfamide for injection, Indinavir Capsules, Irinotecan Hydrochloride for Injection, Irinotecan Hydrochloride Injection, Mercaptopurine Tablets, Methotrexate For Inj, Methotrexate for injection, Methotrexate Tablets, Mitomycin For Inj, Mitoxantrone Hydrochloride for Injection, Nedaplatin for Injection, Nevirapine Tablets, Ondansetron Hydrochloride for Injection, Ondansetron Hydrochloride Injection, Oxaliplatin for Injection, Paclitaxel Injection, Pemetrexed disodium for Injection, Stavudine Capsules, Tamoxifen Citrate Tablets, Tegafur Injection, Tegafur Tablets, Topotecan hydrochloride for injection, Vincristine Sulfate For Inj, Vindesine Sulfate for Injection, Vinorelbine Tartrate for Injection, Vinorelbine Tartrate Injection, Zidovudine Injection, Zidovudine Tablets, Zoledronic Acid for Injection, Zoledronic Acid Injection